SAB Biotherapeutics (SABS) PT Lowered to $9 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Emily Bodnar lowered the price target on SAB Biotherapeutics (NASDAQ: SABS) to $9.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
